Corteva (NYSE:CTVA) Rating Lowered to Sell at Wall Street Zen

Corteva (NYSE:CTVA) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports.

Other equities analysts have also recently issued reports about the stock. Oppenheimer cut shares of Corteva from an “outperform” rating to a “market perform” rating in a research report on Friday. KeyCorp upgraded Corteva from a “sector weight” rating to an “overweight” rating and set a $17.00 target price for the company in a research note on Wednesday, October 7th. Royal Bank Of Canada dropped their price objective on Corteva from $17.00 to $11.00 and set an “outperform” rating for the company in a research report on Friday. BMO Capital Markets set a $15.00 price objective on Corteva in a research note on Friday, October 2nd. Finally, Citigroup reduced their price target on shares of Corteva from $13.65 to $10.30 and set a “neutral” rating on the stock in a research note on Friday. Fifteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $52.60.

Corteva Stock Performance

CTVA opened at $9.41 on Friday. The firm has a market cap of $6.28 billion, a P/E ratio of 4.96, a price-to-earnings-growth ratio of 1.72 and a beta of 0.58. Corteva has a 52-week low of $9.01 and a 52-week high of $90.97. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.10 and a current ratio of 1.56. The business’s fifty day moving average is $37.22 and its 200-day moving average is $69.57.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in CTVA. BlackRock Inc. purchased a new position in shares of Corteva during the second quarter valued at about $4,560,180,000. Wellington Management Group LLP lifted its holdings in Corteva by 941.7% in the second quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company’s stock worth $644,720,000 after buying an additional 6,881,875 shares during the period. Jupiter Topco LLC purchased a new stake in Corteva in the second quarter worth about $544,246,000. Bank of America Corp DE bought a new stake in Corteva during the 2nd quarter valued at approximately $484,927,000. Finally, Legal & General Group Plc bought a new stake in Corteva during the 2nd quarter valued at approximately $482,836,000. Institutional investors own 81.54% of the company’s stock.

Corteva News Roundup

These are some of the CTVA news items that stood out recently:

• Positive Sentiment: Corteva pointed to new products and cost-cutting efforts as supports for a potential recovery, though these measures have not offset near-term weakness. Corteva Q3 Earnings Call Highlights Brazil Woes and Outlook Cut
• Neutral Sentiment: Several analysts lowered price targets following the outlook reset. Citigroup and UBS kept neutral ratings, while JPMorgan maintained overweight and RBC kept outperform ratings, signaling some analysts still see potential upside from recent levels. Read More. · Read More. · Read More. · Read More.
• Negative Sentiment: Law firms announced investigations into potential securities-law violations related to company disclosures. These are allegations under investigation, not findings of wrongdoing, but may add uncertainty for investors. Law firm investigation announcement

About Corteva

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.